Vanda Pharmaceuticals (VNDA) Non-Current Debt (2024 - 2026)
Powered by 
Analysis
Vanda Pharmaceuticals (VNDA) Non-Current Debt (2024 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,132.21 Bn | 1,100.80 Bn | 19.71 Bn | 47.86 Bn |
| 2 | Johnson & Johnson | 616.27 Bn | 534.80 Bn | 17.26 Bn | 37.34 Bn |
| 3 | AbbVie | 500.10 Bn | 473.21 Bn | 12.70 Bn | 62.48 Bn |
| 4 | Merck | 366.86 Bn | 321.23 Bn | 12.21 Bn | 51.08 Bn |
| 5 | Novartis Ag | 297.92 Bn | 261.91 Bn | 11.24 Bn | 1.96 Bn |
| 6 | Astrazeneca | 261.53 Bn | 235.22 Bn | 12.86 Bn | 23.68 Bn |
| 7 | Amgen | 234.99 Bn | 190.39 Bn | 7.24 Bn | 51.86 Bn |
| 8 | Gilead Sciences | 190.14 Bn | 164.34 Bn | 6.22 Bn | 23.83 Bn |
| 9 | Pfizer | 169.63 Bn | 116.28 Bn | 10.94 Bn | 60.50 Bn |
| 10 | Vanda Pharmaceuticals | 245.12 Mn | -684.82 Mn | 46.97 Mn | -856,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -856,000.00 |
| Mar 31, 2026 | -776,000.00 |
| Dec 31, 2025 | -640,000.00 |
| Sep 30, 2025 | -517,000.00 |
| Jun 30, 2025 | -425,000.00 |
| Mar 31, 2025 | -409,000.00 |
| Dec 31, 2024 | -155,000.00 |
API Access
Vanda Pharmaceuticals Non-Current Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-debt&ticker=VNDA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-debt", "ticker": "VNDA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-debt&ticker=VNDA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();